Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Novavax, Inc. (the Company) on Form 10-Q for the
period ended June 30, 2005 as filed with the Securities and Exchange Commission on the date hereof
(the Report), I, Dennis W. Genge, Vice-President and Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of
2002, that:
| |
1) |
|
The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and |
| |
| |
2) |
|
The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company. |
| |
|
|
|
|
| |
|
|
| |
By: |
/s/ Dennis W. Genge
|
|
| |
Name: |
Dennis W. Genge |
|
| |
Title: |
Vice President and
Chief Financial Officer |
|
| |
August 9, 2005 |
|
| |
34